Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Etrion to Release Fourth Quarter and Year End 2018 Results on March 13, 2019

March 8, 2019, Geneva, Switzerland – Etrion Corporation (“Etrion” or the “Company”) (TSX: ETX) (OMX: ETX), a solar independent power producer, will release its fourth quarter and year end 2018 results before the market opens on Wednesday, March 13, 2019.   Operations and Finance Update call   A conference call webcast to present the Company’s 2018 Operations and Finance update will be held on Wednesday, March 13, 2019, at 10:00 a.m. Eastern Standard Time (EST) / 4:00 p.m. Central European Time (CET).    Dial-in details:  North America: +1-647-788-4991 / Toll Free: +1-877-291-

Third quarter interim report (05/01/2018 – 01/31/2019)

November – January 2019 Net Sales                                                                                      1 845 (1 430) KSEK Operating result before depreciation (EBITDA)                   -4 744 (-2 426) KSEK Net result                                                                                   -6 147 (-3 724) KSEK Earnings per share                                                                          -0.45 (-0.32) SEK May – January 2019 (Year to date) Net Sales                                                                                      3

Scandion Oncology A/S Obtains Positive Preclinical Results in Antibiotic Resistance

Scandion Oncology A/S (Scandion Oncology) hereby announces that Scandion Oncology, together with University of Copenhagen, has discovered that a number of Scandion Oncology’s compounds are able to overcome antibiotic resistance in bacterial infections through a new mechanism of action. These are findings from preclinical studies. The discovery may pave the way for new drugs for treatment of antibiotic resistance. Scandion Oncology has filed a patent application and owns all rights to this invention. Scandion Oncology is currently exploring the commercial opportunities for these novel

Cereno Scientific strengthens its clinical expertise, establishes Scientific Advisory Board

Cereno Scientific today announced the establishment of a Scientific Advisory Board, whose purpose is to strengthen the transfer of knowledge from academic research into a business environment. Dr. Bertram Pitt, a professor at the University of Michigan School of Medicine with long-standing experience and a strong reputation in the field of cardiovascular diseases, has accepted the offer to become the chair of the board.“By establishing a Scientific Advisory Board, we are strengthening the company’s competence and clinical expertise, which is important for quality assurance in our clinical

SniffPhone detects cancer from breath − VTT involved in the development of a cancer screening device

SniffPhone, currently in its prototype phase, enables early diagnosis of gastric cancer from a person’s exhaled breath. The new method may revolutionise cancer screening all over the world. VTT has participated to the development of SniffPhone prototype and concept with nine other project partners. SniffPhone is a small sensor device developed for cancer screening that can be attached to a smartphone. In practice, the user holds the device in front of his or her mouth and exhales onto the sensor to give breath sample. The device measures the contained Volatile Organic Compounds (VOCs)

DBP partners with Webpharma SPT in Norway

Double Bond Pharmaceuticals subsidiary Drugsson has signed a distribution agreement with Webpharma SPT in Norway. According to the agreement, Webpharma will be Drugsson's wholesaler and distribution partner in the Norwegian market. "With this agreement, we now have a partner who has a great experience in the Norwegian market," comments Igor Lokot, CEO of Double Bond Pharma and Drugsson AB. – This collaboration will substantially propel Drugssons expansion to Norway”. Webpharma SPT are also active on the health care professional market and supplies pharmaceuticals to clinics and

Tieto appoints Thomas Nordås as Managing Partner in Norway to accelerate implementation of the company’s newly launched strategy

Tieto appoints Thomas Nordås (MBA) as Managing Partner, Norway and a member of the company’s Leadership Network as of 1 June 2019.  Nordås will be responsible for driving growth for Tieto in the Norwegian market, establishing Digital Experience business with consulting services to facilitate innovation and renewal for Norwegian customers. The Digital Experience business at Tieto, including design of service experiences and smart use of data, will form the core of the company’s new strategy and future growth. Nordås will also contribute to continued healthy development of industry

Exercise period for BrainCool’s warrants, TO2 2018-2021, 19 March – 2 April 2019

As part of our agreement with L1 Capital, BrainCool has distributed free warrants to the company's shareholders to reduce dilution. During the period of March 19 to April 2, 2019, holders of TO2 Warrants can exercise the Warrants and subscribe for new shares. One (1) TO2 warrant can be exchanged for one (1) share, at a price of 7 SEK. The current market price is below the exercise price. Unless the market price exceeds the exercise price, it is not beneficial to subscribe in the current exercise period. Therefore, the application form has not been sent to the shareholders. If

Elkem ASA – Annual report for 2018

Oslo, 11 March 2019 Elkem ASA has today published its annual report, comprising the sustainability report, for the financial year ended 31 December 2018. The annual report will be available on Elkem's website: www.elkem.com  This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act. For further queries, please contact:Odd-Geir LyngstadVP Treasury and Investor RelationsTel: +47 976 72 806 About Elkem Founded in 1904, Elkem is one of the world’s leading

Ahlstrom-Munksjö coated products extends their product line of Aerobak™ liners for advanced composites

AHLSTROM-MUNKSJÖ OYJ, PRESS RELEASE, MARCH 11, 2017 at 9:00 EETAhlstrom-Munksjö’s North America Specialty Solutions Coated Products team announced today an extension to their brand of release liners used in the manufacture of Advanced Composites. In collaboration with our suppliers and customers, the product was designed with specific properties and performance characteristics to meet the challenges encountered with low tack prepregs and demanding ATL processes. This new line of products represents years of development and experience addressing the constant evolution of products used for

Share buy-backs in Nordic Waterproofing (to secure the Company’s incentive programs) during week 10, 2019

During the period March 4, 2019, until and including March 8, 2019, Nordic Waterproofing Holding A/S has repurchased in total 16,316 own shares (ISIN: DK0060738409). The share buy-backs form part of the SEK 18 million share buy-back program that Nordic Waterproofing announced on December 20, 2018, in order to secure the Company’s incentive programs. The share buy-back program, which runs between December 20, 2018, and March 29, 2019, is being carried out in accordance with the Market Abuse Regulation (EU) No 596/2014 (“MAR”) and the Commission Delegated Regulation (EU) No 2016/1052 (the “Safe

IRRAS Strengthens Executive Team with Addition of Dr. Vinny Podichetty as Vice President of Clinical Affairs

Stockholm, March 11, 2019 – IRRAS AB (Nasdaq First North Premier: IRRAS), a commercial-stage medical-technology company announced today that it has appointed Vinny Podichetty, MD, MS. as Vice President of Global Clinical Affairs. Dr. Podichetty will report to the President and Chief Executive Officer, Kleanthis G. Xanthopoulos, Ph.D., and will serve as a member of the Executive Management team. Dr. Podichetty brings more than 17 years of experience in clinical, medical and regulatory affairs and global execution of clinical trials for medical devices. He has developed and successfully

Veidekke ASA: Reduced pressure in the construction market

Veidekke expects a moderate decline in production in the Scandinavian building construction sector in 2019 and 2020, but a modest increase in civil engineering production. These developments are forecast to reduce pressure in the market and improve access to construction capacity and skilled labour throughout the supply chain.“Production in the sector increased by more than 40 per cent over the past four years, and, in our opinion, the market can now accommodate a moderate decline”, says Kristoffer Eide Hoen Director of Analysis in Veidekke. Total production in building construction and

Notice of Annual General Meeting in Ovzon (publ)

The shareholders of Ovzon AB (publ), reg. no. 559079-2650, (the "Company"), are hereby convened to the annual general meeting to be held on Wednesday 10th of April 2019, at 15:00 at the Company's premises at Anderstorpsvägen 10 in Solna. The doors to the meeting will open at 14:45.Right to attend the annual general meeting and notice: Shareholders wishing to attend the annual general meeting must:       i.         on the record date, which is Thursday 4 April 2019, be registered in the share register maintained by Euroclear Sweden AB. Shareholders, whose shares are registered in the

Research seminar 19 March 2019: Prevalence of thermotolerant campylobacter in agricultural pests

Researcher Jouni Tikkanen from the Microbiology Unit, Division of Food and Feed Microbiology at the Finnish Food Authority discusses his Master’s thesis research on thermotolerant campylobacter.The seminar presents the results of the joint project on pests by the Finnish Food Authority (formerly Evira) and Natural Resources Institute Finland (Luke). The thesis studied thermotolerant campylobacter found in rodents and shrews encountered in the vicinity of pig and cattle farms. The research seminar will be held at Lecture hall C111 in Mustialankatu 3, Viikki, Helsinkion Tuesday 19 March

Sweco to supervise the renovation of the Belliard and Loi tunnels in Brussels

The consortium of Sweco and BG Ingénieurs Conseils has been appointed by Brussels Mobility for the design and supervision of the large-scale renovation of the Belliard and Loi tunnels. The order value is SEK 56 million (EUR 5.3 million).The tunnels, located in the heart of the Belgian capital, are being modernized with special attention to safety, design and sustainability. The consortium led by Sweco will assist the customer with detailed design, preparation of technical specifications, procurement support and supervision of the renovation. "This is a complex tunnel project, close to

Read original

Statement by the board of directors of Acando in relation to CGI’s public offer

The board of directors of Acando has resolved to unanimously recommend the shareholders of Acando to accept the public offer made by CGI.Background This statement is made by the board of directors of Acando AB (publ) (“Acando” or the “Company”) pursuant to section II.19 of Nasdaq Stockholm’s Takeover Rules (the “Takeover Rules”). CGI Inc., a company with registered office in Montréal, Canada, whose shares are listed on Toronto Stock Exchange and New York Stock Exchange (”CGI”), has today, through its indirect wholly-owned subsidiary CGI Nordic Holdings Limited, announced a public

CGI announces a recommended cash offer to the shareholders of Acando

The Offer is not being made, and this press release may not be distributed, directly or indirectly, in or into, nor will any tender of shares be accepted from or on behalf of holders in, any jurisdiction in which the making of the Offer, the distribution of this press release or the acceptance of any tender of shares would contravene applicable laws or regulations or require further offer documents, filings or other measures in addition to those required under Swedish law.   CGI Nordic Holdings Limited (“CGI Nordic”), a wholly owned indirect subsidiary of CGI Inc. (“CGI”), announces a

Share buy-backs in Telia Company during week 10 2019

During the period March 4, 2019, until March 8, 2019, Telia Company AB (publ) (LEI code 213800FSR9RNDUOTXO25) has repurchased in total 2,120,000 own shares (ISIN: SE0000667925). The share buy-backs form part of the SEK 5 billion share buy-back programme that Telia Company announced on April 20, 2018. The share buy-back programme, which runs between April 23, 2018, and March 22, 2019, is being carried out in accordance with the Market Abuse Regulation (EU) No 596/2014 ("MAR") and the Commission Delegated Regulation (EU) No 2016/1052 (the "Safe Harbour Regulation").During the period March 4,

Panoro Energy: First post-acquisition crude oil lifting from Tunisia

Oslo, 11 March 2019 - Panoro Energy ASA (the “Company” or “Panoro” with OSE ticker: “PEN”) is pleased to provide an update on lifting operations in Tunisia. The first cargo of approximately 151,000 barrels of Rhemoura blend crude oil has been lifted from La Skhirra Terminal in Tunisia on 6 March 2019. The lifting operations were completed successfully and without any delays or incidents. The pricing for this cargo was based on Rhemoura blend which is at a modest discount to Dated Brent in line with the differentials achieved in the recent past. Panoro’s net participation in this lifting

Africa Energy to Present at Investor Meeting in Stockholm

March 11, 2019 – Africa Energy Corp. (TSX Venture: AFE) (Nasdaq First North: AEC) (“Africa Energy” or the “Company”), an oil and gas company with exploration assets offshore South Africa and Namibia, announces that the Company’s management will be presenting to shareholders and investors at a town hall meeting in Stockholm, Sweden on Wednesday, March 13, 2019, at 18:30 Central European Time (CET). The town hall meeting will be held at Näringslivets Hus on Storgatan 19 in Stockholm (local Industrisalen). Shareholders and investors are requested to confirm their attendance beforehand by

Persons with Alzheimer’s disease have a higher risk of head injuries

Persons with Alzheimer’s disease have approximately 30% higher risk of head injuries, and 50% higher risk of traumatic brain injuries than persons without Alzheimer’s disease, a recent study from University of Eastern Finland shows. The results were published in Journal of Epidemiology and Community Health. This is the first study that has assessed the incidence of head and traumatic brain injuries among persons with Alzheimer’s disease. Falls are the most common cause of head injuries in older adults, and persons with Alzheimer’s disease are known to have a higher risk of falling. The

WOW air hf. – Notice of a written procedure to be distributed to bondholders next week

Reykjavik, Iceland – March 9, 2019  Reference is made to previous announcements concerning the ongoing negotiations between the shareholders of WOW air hf. (“WOW”) and Indigo Partners LLC (“Indigo”). Although no agreement has been reached, the parties continue to work in good faith towards closing an investment as soon as practicable following successful completion of due diligence and satisfaction of other conditions precedent pursuant to a Share Purchase Agreement (the "Share Purchase Agreement") to be entered into between an SPV formed and controlled by Indigo Partners (the "Indigo

There are no items matching the current filter
There are no more items matching the current filter
Back to top